GPs warned of inhaler shortages
Australian supply shortages have hit several AstraZeneca drugs – five formulations of candesartan cilextetil and four inhaled respiratory medications, the company has announced.
In a letter to doctors, AstraZeneca said pharmacies were expected to be out of supply of the following drugs and dosages through May and early June:
- Candesartan cilexetil (Atacand; 4mg, 8mg, 16mg and 32mg)
- Candesartan cilexetil and hydrochlorothiazide (Atacand Plus; 16/12.5mg)
- Budesonide (Pulmicort; 200mcg and 400mcg Turbuhalers